PET imaging of hypoxia.

Imaging hypoxia to improve radiotherapy outcome. Nat Rev Clin Oncol (2012) 1.57

Dosimetry of 60/61/62/64Cu-ATSM: a hypoxia imaging agent for PET. Eur J Nucl Med Mol Imaging (2005) 1.05

Methodology for quantitative rapid multi-tracer PET tumor characterizations. Theranostics (2013) 0.98

Practical dynamic contrast enhanced MRI in small animal models of cancer: data acquisition, data analysis, and interpretation. Pharmaceutics (2012) 0.94

Quantitative multimodality imaging in cancer research and therapy. Nat Rev Clin Oncol (2014) 0.90

Species dependence of [64Cu]Cu-Bis(thiosemicarbazone) radiopharmaceutical binding to serum albumins. Nucl Med Biol (2008) 0.83

One-stop-shop tumor imaging: buy hypoxia, get lactate free. J Clin Invest (2008) 0.82

Where are we with imaging oxygenation in human tumours? Cancer Imaging (2005) 0.81

Elucidation of the human serum albumin (HSA) binding site for the Cu-PTSM and Cu-ATSM radiopharmaceuticals. J Pharm Sci (2009) 0.80

Imaging with non-FDG PET tracers: outlook for current clinical applications. Insights Imaging (2010) 0.75

Efficient production of high specific activity 64Cu using a biomedical cyclotron. Nucl Med Biol (1997) 3.25

A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann Neurol (1984) 3.11

Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina. Lancet (1997) 2.88

In vivo transchelation of copper-64 from TETA-octreotide to superoxide dismutase in rat liver. Bioconjug Chem (2000) 2.30

Metabolic flare: indicator of hormone responsiveness in advanced breast cancer. J Clin Oncol (2001) 2.20

A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys (2001) 2.15

Radiometal-labeled agents (non-technetium) for diagnostic imaging. Chem Rev (1999) 1.93

Increased frequency of rheumatoid factor precursor B lymphocytes after immunization of normal adults with tetanus toxoid. Clin Exp Immunol (1983) 1.88

Indium-111-labeled leukocytes for the localization of abscesses: preparation, analysis, tissue distribution, and comparison with gallium-67 citrate in dogs. J Lab Clin Med (1977) 1.87

Temporal dependence of beneficial effects of coronary thrombolysis characterized by positron tomography. Am J Med (1982) 1.85

Functional consequences of posttranslational isomerization of Ser46 in a calcium channel toxin. Science (1994) 1.73

High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment. Proc Natl Acad Sci U S A (2000) 1.69

Evaluation of 64Cu-ATSM in vitro and in vivo in a hypoxic tumor model. J Nucl Med (1999) 1.62

Indium-LLL labeled platelets: studies on preparation and evaluation of in vitro and in vivo functions. Thromb Res (1976) 1.61

Intracellular metabolism of indium-111-DTPA-labeled receptor targeted proteins. J Nucl Med (1993) 1.56

Relationship between lipophilicity and brain extraction of C-11-labeled radiopharmaceuticals. J Nucl Med (1983) 1.55

Breast cancer: PET imaging of estrogen receptors. Radiology (1988) 1.53

The in vivo behavior of copper-64-labeled azamacrocyclic complexes. Nucl Med Biol (1998) 1.52

Tumor uptake of copper-diacetyl-bis(N(4)-methylthiosemicarbazone): effect of changes in tissue oxygenation. J Nucl Med (2001) 1.51

Positron emission tomographic assessment of "metabolic flare" to predict response of metastatic breast cancer to antiestrogen therapy. Eur J Nucl Med (1999) 1.49

MPTP-induced up-regulation of in vivo dopaminergic radioligand-receptor binding in humans. Neurology (1987) 1.49

Blood-brain barrier permeability of 11C-labeled alcohols and 15O-labeled water. Am J Physiol (1976) 1.48

In vivo comparison of copper blood-pool agents: potential radiopharmaceuticals for use with copper-62. J Nucl Med (1991) 1.46

In vivo delineation of myocardial hypoxia during coronary occlusion using fluorine-18 fluoromisonidazole and positron emission tomography: a potential approach for identification of jeopardized myocardium. J Am Coll Cardiol (1990) 1.42

Characterization of acetate metabolism in tumor cells in relation to cell proliferation: acetate metabolism in tumor cells. Nucl Med Biol (2001) 1.39

Preparation and evaluation of 111In-labeled leukocytes as an abscess imaging agent in dogs. Radiology (1976) 1.36

Positron emission tomography with 2-[18F]Fluoro-2-deoxy-D-glucose and 16alpha-[18F]fluoro-17beta-estradiol in breast cancer: correlation with estrogen receptor status and response to systemic therapy. Clin Cancer Res (1996) 1.35

Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FDG-PET and in vitro receptor assays. J Nucl Med (1995) 1.34

Copper-64-labeled antibodies for PET imaging. J Nucl Med (1992) 1.29

Homodimeric and heterodimeric bis(amino thiol) oxometal complexes with rhenium(V) and technetium(V). Control of heterodimeric complex formation and an approach to metal complexes that mimic steroid hormones. J Med Chem (1994) 1.29

Quantification of regional myocardial blood flow in vivo with H215O. Circulation (1984) 1.24

Vocal cord dysfunction in a child with asthma. J Asthma (1991) 1.23

RadioimmunoPET: detection of colorectal carcinoma with positron-emitting copper-64-labeled monoclonal antibody. J Nucl Med (1995) 1.21

Positron tomographic assessment of 16 alpha-[18F] fluoro-17 beta-estradiol uptake in metastatic breast carcinoma. J Nucl Med (1991) 1.21

Radioimmunotherapy with a 64Cu-labeled monoclonal antibody: a comparison with 67Cu. Proc Natl Acad Sci U S A (1996) 1.20

Scintigraphic detection of atherosclerotic lesions and venous thrombi in man by indium-111-labelled autologous platelets. Lancet (1978) 1.17

The measure in vivo of regional cerebral oxygen utilization by means of oxyhemoglobin labeled with radioactive oxygen-15. J Clin Invest (1970) 1.17

Positron emission tomographic measurement of cerebral blood flow and permeability-surface area product of water using [15O]water and [11C]butanol. J Cereb Blood Flow Metab (1987) 1.16

High purity production and potential applications of copper-60 and copper-61. Nucl Med Biol (1999) 1.15

Indium-111-labeled cellular blood components: mechanism of labeling and intracellular location in human neutrophils. J Nucl Med (1977) 1.10

NCA 16 alpha-[18F]fluoroestradiol-17 beta: the effect of reaction vessel on fluorine-18 resolubilization, product yield, and effective specific activity. Int J Rad Appl Instrum A (1986) 1.10

Preparation of four fluorine- 18-labeled estrogens and their selective uptakes in target tissues of immature rats. J Nucl Med (1984) 1.08

Tomographic images of blood pool and perfusion in brain and heart. J Nucl Med (1976) 1.08

Inhaled steroids and severe viral infections. J Asthma (1994) 1.07

Pill swallowing ability and training in children 6 to 11 years of age. Clin Pediatr (Phila) (2006) 1.06

Retention mechanism of hypoxia selective nuclear imaging/radiotherapeutic agent cu-diacetyl-bis(N4-methylthiosemicarbazone) (Cu-ATSM) in tumor cells. Ann Nucl Med (2001) 1.06

Comparison of four bifunctional chelates for radiolabeling monoclonal antibodies with copper radioisotopes: biodistribution and metabolism. Bioconjug Chem (1997) 1.06

Small animal imaging. current technology and perspectives for oncological imaging. Eur J Cancer (2002) 1.05

Radiotoxicity of 5-[123I]iodo-2'-deoxyuridine in V79 cells: a comparison with 5-[125I]iodo-2'-deoxyuridine. Radiat Res (1989) 1.05

Preclinical evaluation of fluorine-18-labeled androgen receptor ligands in baboons. J Nucl Med (1996) 1.05

In vitro and in vivo evaluation of copper-64-octreotide conjugates. J Nucl Med (1995) 1.04

Evaluation of 62Cu labeled diacetyl-bis(N4-methylthiosemicarbazone) as a hypoxic tissue tracer in patients with lung cancer. Ann Nucl Med (2000) 1.01

Differences in the sites of iodination of proteins following four methods of radioiodination. Biochim Biophys Acta (1977) 1.01

The determination of regional cerebral blood flow by means of water labeled with radioactive oxygen 15. Radiology (1969) 1.01

Lethality of Auger electrons from the decay of bromine-77 in the DNA of mammalian cells. Radiat Res (1982) 1.01

Scintigraphic detection of carotid atherosclerosis with indium-111-labeled autologous platelets. Circulation (1980) 1.00

Fluorine-18 labeling of proteins. J Nucl Med (1987) 1.00

Copper-62-labeled pyruvaldehyde bis(N4-methylthiosemicarbazonato)copper(II): synthesis and evaluation as a positron emission tomography tracer for cerebral and myocardial perfusion. J Nucl Med (1990) 0.99

Experimental fecal transmission of human cryptosporidia to pigs, and attempted treatment with an ornithine decarboxylase inhibitor. Vet Pathol (1982) 0.99

Isolated absence of nasal cilia: a case report. Ann Allergy (1984) 0.99

Synthesis of 11 beta-[18F]fluoro-5 alpha-dihydrotestosterone and 11 beta-[18F]fluoro-19-nor-5 alpha-dihydrotestosterone: preparation via halofluorination-reduction, receptor binding, and tissue distribution. J Med Chem (1995) 0.98

Fluorine-18-labeled androgens: radiochemical synthesis and tissue distribution studies on six fluorine-substituted androgens, potential imaging agents for prostatic cancer. J Nucl Med (1992) 0.98

Comparative studies of Cu-64-ATSM and C-11-acetate in an acute myocardial infarction model: ex vivo imaging of hypoxia in rats. Nucl Med Biol (1999) 0.98

Effect of dosing schedule on efficacy of beclomethasone dipropionate aerosol in chronic asthma. Am Rev Respir Dis (1985) 0.97

Gallium-68 labeling of albumin and albumin microspheres. J Nucl Med (1979) 0.97

Evaluation of the role of cellular hypoxia in sepsis by the hypoxic marker [18F]fluoromisonidazole. Am J Physiol (1991) 0.96

Biodistribution and metabolism of targeted and nontargeted protein-chelate-gadolinium complexes: evidence for gadolinium dissociation in vitro and in vivo. Magn Reson Imaging (1995) 0.96

Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma. J Allergy Clin Immunol (2000) 0.96

Characterization of the uptake of 16 alpha-([18F]fluoro)-17 beta-estradiol in DMBA-induced mammary tumors. Int J Rad Appl Instrum B (1987) 0.94

Standardization of cardiac troponin I assays: round Robin of ten candidate reference materials. Clin Chem (2001) 0.94

The dependence of accumulation of 13NH3 by myocardium on metabolic factors and its implications for quantitative assessment of perfusion. Circulation (1980) 0.94

Indium-III: a new radionuclide label for studying human platelet kinetics. Br J Haematol (1979) 0.94

Caution with inhaled corticosteroids in childhood asthma. West J Med (1995) 0.93

Gallium radiopharmaceutical chemistry. Int J Rad Appl Instrum B (1989) 0.92

Identification of metabolites of 111In-diethylenetriaminepentaacetic acid-monoclonal antibodies and antibody fragments in vivo. Cancer Res (1995) 0.92

Dosimetry of copper-64-labeled monoclonal antibody 1A3 as determined by PET imaging of the torso. J Nucl Med (1995) 0.92

Fluorine-18-labeled progestin 16 alpha, 17 alpha-dioxolanes: development of high-affinity ligands for the progesterone receptor with high in vivo target site selectivity. J Med Chem (1995) 0.91

The development of estrogen and progestin radiopharmaceuticals for imaging breast cancer. Anticancer Res (1997) 0.90

In vivo kinetics of [18F](N-methyl)benperidol: a novel PET tracer for assessment of dopaminergic D2-like receptor binding. J Cereb Blood Flow Metab (1997) 0.90

Novel gallium(III) complexes transported by MDR1 P-glycoprotein: potential PET imaging agents for probing P-glycoprotein-mediated transport activity in vivo. Chem Biol (2000) 0.90

Workshop on the production, application and clinical translation of ''non-standard'' PET nuclides: a meeting report. Q J Nucl Med Mol Imaging (2007) 0.90

Measurement of regional pulmonary blood flow with PET. J Nucl Med (1995) 0.90

Influence of endothelial cell seeding on platelet deposition and patency in small-diameter Dacron arterial grafts. J Vasc Surg (1984) 0.89

Sarcoma of the prostate. Cancer (1976) 0.89

N,N'-ethylene-di-L-cysteine (EC) complexes of Ga(III) and In(III): molecular modeling, thermodynamic stability and in vivo studies. Nucl Med Biol (1995) 0.89

Copper-62 ATSM as a hypoxic tissue tracer in myocardial ischemia. Ann Nucl Med (2001) 0.89

Unsatisfactory biologic behavior of I-fibrinogen labeled by the chloramine-T method. J Lab Clin Med (1973) 0.88

Radiation dosimetry of [18F] (N-methyl)benperidol as determined by whole-body PET imaging of primates. Nucl Med Biol (1997) 0.88

Methodology for the synthesis and specific activity determination of 16 alpha-[77Br]-bromoestradiol-17 beta and 16 alpha-[77Br]-11 beta-methoxyestradiol-17 beta, two estrogen receptor-binding radiopharmaceuticals. Int J Appl Radiat Isot (1982) 0.88

Characterization of nontransmural myocardial infarction by positron-emission tomography. Circulation (1982) 0.88

Gallium-68 labeled red cells and platelets: new agents for positron tomography. J Nucl Med (1977) 0.88

Metabolic imaging with gallium-68- and indium-111-labeled low-density lipoprotein. J Nucl Med (1991) 0.87

Regional myocardial perfusion assessed with generator-produced copper-62-PTSM and PET. J Nucl Med (1996) 0.87

A dose-response study of the bronchodilator action of azelastine in asthma. J Allergy Clin Immunol (1987) 0.87

Detection of remote myocardial infarction in patients with positron emission transaxial tomography and intravenous 11C-palmitate. Circulation (1977) 0.86

Comparison of In-111-labeled platelets and iodinated fibrinogen for the detection of deep vein thrombosis. J Nucl Med (1978) 0.86

Assessment of regional myocardial and renal blood flow with copper-PTSM and positron emission tomography. Circulation (1990) 0.86

Assessment of 21-[18F]fluoro-16 alpha-ethyl-19-norprogesterone as a positron-emitting radiopharmaceutical for the detection of progestin receptors in human breast carcinomas. J Nucl Med (1991) 0.86

External detection and visualization of myocardial ischemia with 11C-substrates in vitro and in vivo. Circ Res (1976) 0.86

Kinetics of copper-PTSM in isolated hearts: a novel tracer for measuring blood flow with positron emission tomography. J Nucl Med (1989) 0.86